Cargando…

Enhancing Clinical Diagnosis for Patients With Persistent Pulmonary Abnormalities After COVID-19 Infection: The Potential Benefit of (68)Ga-FAPI PET/CT

Coronavirus disease 2019 (COVID-19)–related pneumonia challenges clinical practice. We explore the potential diagnostic benefit of PET/CT to establish the underlying inflammatory or fibrotic repair processes in prolonged structural lung abnormalities in COVID-19 patients. PATIENTS AND METHODS: Six p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sviridenko, Anna, Boehm, Anna, di Santo, Gianpaolo, Uprimny, Christian, Nilica, Bernhard, Fritz, Josef, Giesel, Frederik L., Haberkorn, Uwe, Sahanic, Sabina, Decristoforo, Clemens, Tancevski, Ivan, Widmann, Gerlig, Loeffler-Ragg, Judith, Virgolini, Irene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653058/ https://www.ncbi.nlm.nih.gov/pubmed/36257062 http://dx.doi.org/10.1097/RLU.0000000000004437

Ejemplares similares

(68)Ga- or (18)F-FAPI PET/CT—what it can and cannot
por: Mori, Yuriko, et al.
Publicado: (2023)

[(68) Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease
por: Conen, Patrick, et al.
Publicado: (2022)

(68)Ga-FAPI-PET/CT in patients with various gynecological malignancies
por: Dendl, Katharina, et al.
Publicado: (2021)

Comparison of Early Imaging and Imaging 60 min Post-Injection after Forced Diuresis with Furosemide in the Assessment of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CT
por: Bayerschmidt, Steffen, et al.
Publicado: (2021)

Distinguishing Benign and Malignant Findings on [(68) Ga]-FAPI PET/CT Based on Quantitative SUV Measurements
por: Dabir, M., et al.
Publicado: (2022)

Assessing self-medication for obstructive airway disease during COVID-19 using Google Trends
por: Sahanic, Sabina, et al.
Publicado: (2020)

Impact of (68)Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
por: Koerber, Stefan A., et al.
Publicado: (2023)

Comparison of early and late (68)Ga-FAPI-46-PET in 33 patients with possible recurrence of pancreatic ductal adenocarcinomas
por: Hoppner, Jorge, et al.
Publicado: (2023)

Pneumonia with Intense (68)Ga-FAPI Uptake Mimicking Metastasis on (68)Ga-FAPI PET/CT in a Patient with Rectal Cancer
por: Erol Fenercioğlu, Özge, et al.
Publicado: (2023)

Early Detection of Checkpoint Inhibitor-Associated Myocarditis Using (68)Ga-FAPI PET/CT
por: Finke, Daniel, et al.
Publicado: (2021)

Localization of Pyelonephritis by (68)Ga-FAPI PET CT
por: Jagtap, Rajlaxmi Rangrao, et al.
Publicado: (2023)

Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUV(max) reference range for management of pancreatic neuroendocrine tumours
por: Virgolini, Irene, et al.
Publicado: (2016)

Head-to-head Intra-individual Comparison of [(68)Ga]-FAPI and [(18)F]-FDG PET/CT in Patients with Bladder Cancer
por: Novruzov, E., et al.
Publicado: (2022)

(68)Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers
por: Giesel, Frederik L., et al.
Publicado: (2019)

The (68)Ga/(177)Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up
por: Maffey-Steffan, Johanna, et al.
Publicado: (2019)

Subclass Analysis of Malignant, Inflammatory and Degenerative Pathologies Based on Multiple Timepoint FAPI-PET Acquisitions Using FAPI-02, FAPI-46 and FAPI-74
por: Glatting, Frederik M., et al.
Publicado: (2022)

Radiopharmaceutical Formulation and Preclinical Testing of (68)Ga-Labeled DOTA-MGS5 for the Regulatory Approval of a First Exploratory Clinical Trial
por: Hörmann, Anton A., et al.
Publicado: (2021)

Fully-automated production of [(68)Ga]Ga-FAPI-46 for clinical application
por: Spreckelmeyer, Sarah, et al.
Publicado: (2020)

Direct comparison of (68)Ga-DOTA-TOC and (18)F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle
por: Nilica, Bernhard, et al.
Publicado: (2016)

Performance and Prospects of [(68)Ga]Ga-FAPI PET/CT Scans in Lung Cancer
por: Borgonje, Paula E., et al.
Publicado: (2022)

Fully automated radiosynthesis of [(68)Ga]Ga-FAPI-46 with cyclotron produced gallium
por: Rosenberg, Adam J., et al.
Publicado: (2023)

Automated Synthesis of [(68)Ga]Ga-FAPI-46 on a Scintomics GRP Synthesizer
por: Plhak, Elisabeth, et al.
Publicado: (2023)

FAPI-04 Uptake in Healthy Tissues of Cancer Patients in (68)Ga-FAPI-04 PET/CT Imaging
por: Gündoğan, Cihan, et al.
Publicado: (2021)

Ga68-FAPI Imaging and Lu177-FAPI Therapy in a Case of Metastatic Solitary Fibrous Tumor
por: Luthra, Karuna, et al.
Publicado: (2023)

Impact of Vitamin D Deficiency on COVID-19—A Prospective Analysis from the CovILD Registry
por: Pizzini, Alex, et al.
Publicado: (2020)

Head-to-head intra-individual comparison of biodistribution and tumor uptake of (68)Ga-FAPI and (18)F-FDG PET/CT in cancer patients
por: Giesel, Frederik L., et al.
Publicado: (2021)

Fully Automated Production of [(68)Ga]GaFAPI-46 with Gallium-68 from Cyclotron Using Liquid Targets
por: Fonseca, Alexandra I., et al.
Publicado: (2023)

Dynamic PET/CT Imaging of (68)Ga-FAPI-04 in Chinese Subjects
por: Wang, Shuailiang, et al.
Publicado: (2021)

Clinical Significance of Diffusely Increased Uptake of (68)Ga-FAPI in Thyroid Gland
por: Liu, Huipan, et al.
Publicado: (2021)

(68)Ga-FAPI-04 PET/CT Findings in Patients with Liver Cirrhosis
por: Tatar, Gamze, et al.
Publicado: (2023)

Correlation between [(68)Ga]Ga-FAPI-46 PET Imaging and HIF-1α Immunohistochemical Analysis in Cervical Cancer: Proof-of-Concept
por: Mokoala, Kgomotso M. G., et al.
Publicado: (2023)

Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F]FDG Uptake in Esophageal Cancer
por: Liu, Huipan, et al.
Publicado: (2022)

Non-tumoral uptake of (68)Ga-FAPI-04 PET: A retrospective study
por: Qi, Na, et al.
Publicado: (2022)

Investigating phenotypes of pulmonary COVID-19 recovery: A longitudinal observational prospective multicenter trial
por: Sonnweber, Thomas, et al.
Publicado: (2022)

Pulmonary recovery from COVID-19 in patients with metabolic diseases: a longitudinal prospective cohort study
por: Sonnweber, Thomas, et al.
Publicado: (2023)

Assessment of myocardial fibrosis in patients with systemic sclerosis using [(68)Ga]Ga-FAPI-04-PET-CT
por: Treutlein, Christoph, et al.
Publicado: (2022)

Imaging Properties and Tumor Targeting of (68)Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients
por: Gruber, Leonhard, et al.
Publicado: (2022)

FAPI-74 PET/CT Using Either (18)F-AlF or Cold-Kit (68)Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients
por: Giesel, Frederik L., et al.
Publicado: (2021)

Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma
por: Iglseder, Sarah, et al.
Publicado: (2023)

Improved cancer detection in Waldeyer’s tonsillar ring by (68)Ga-FAPI PET/CT imaging
por: Serfling, S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h4odak8qdg7iknfkejmjfrplem